OMB Completes Review Of FDA’s Cannabis Research Draft Guide

By Beth Wang / July 8, 2020 at 4:58 PM

The White House Office of Management and Budget last week completed its review of FDA’s draft guidance on quality considerations for clinical research on cannabis.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.